EAGLE PHARMACEUTICALS, INC. Quarterly Other Liabilities, Noncurrent in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Eagle Pharmaceuticals, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2018 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Other Liabilities, Noncurrent for the quarter ending June 30, 2023 was $4.26M, a 88.7% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $4.26M +$2M +88.7% Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $4.69M +$2.13M +83.1% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $5.3M +$2.39M +82.5% Dec 31, 2022 10-Q/A 2023-08-09
Q3 2022 $1.87M -$1.17M -38.5% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.26M -$1.1M -32.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $2.56M -$1.1M -30% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $2.9M -$1.06M -26.7% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $3.05M +$204K +7.17% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $3.36M -$1K -0.03% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.66M +$210K +6.08% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3.96M +$959K +32% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $2.84M -$383K -11.9% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $3.36M +$1.8M +115% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.45M +$584K +20.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3M +$3M Dec 31, 2019 10-K 2021-03-05
Q3 2019 $3.23M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.56M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.87M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.